Goldsboro, North Carolina Clinical Trials

A listing of Goldsboro, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 54 clinical trials
featured
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Translocations Who Failed Previous Therapy

A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Translocations Who Failed Previous Therapy

Contact Incyte Corporation Call Center at 1.855.463.3463
 (5.7 away) Contact site
  • 600 views
  • 25 Mar, 2021
  • +13 other locations
Statins and Breast Cancer Biomarkers

There is laboratory evidence that cholesterol lowering medications (statins) inhibit the growth of breast cancer cells. Clinical studies are controversial but some show that women taking statins are less likely to get breast cancer. This ongoing randomized trial compares one-year of atorvastatin (Lipitor™) or placebo for lowering mammography-defined breast density …

ductal carcinoma in situ
Southeastern Medical Oncology Center
 (9.6 away) Contact site
  • 50 views
  • 07 Nov, 2020
  • +2 other locations
S0820 Adenoma and Second Primary Prevention Trial

The investigators hypothesize that the combination of eflornithine and sulindac will be effective in reducing a three-year event rate of adenomas and second primary colorectal cancers in patients previously treated for Stages 0 through III colon or rectal cancer.

anticoagulants
unstable angina
adenoma
aspirin
rectal carcinoma
Southeastern Medical Oncology Center-Goldsboro
 (9.6 away) Contact site
  • 2518 views
  • 03 Mar, 2021
  • +1033 other locations
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy

This randomized phase III trial studies how well cisplatin or carboplatin (platinum based chemotherapy) works compared to capecitabine in treating patients with remaining (residual) basal-like triple-negative breast cancer following chemotherapy after surgery (neoadjuvant). Drugs used in chemotherapy, such as cisplatin, carboplatin and capecitabine, work in different ways to stop the …

metastasis
lobular carcinoma
adjuvant therapy
human epidermal growth factor
ductal carcinoma in situ
Southeastern Medical Oncology Center-Goldsboro
 (9.6 away) Contact site
  • 508 views
  • 24 Jan, 2021
  • +702 other locations
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

This randomized phase III trial studies how well doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel with or without carboplatin work in treating patients with triple-negative breast cancer. Drugs used in chemotherapy, such as doxorubicin hydrochloride, cyclophosphamide, paclitaxel, and carboplatin, work in different ways to stop the growth of tumor cells, …

metastasis
estrogen receptor
platelet count
human epidermal growth factor
estrogen
Southeastern Medical Oncology Center-Goldsboro
 (9.6 away) Contact site
  • 814 views
  • 24 Jan, 2021
  • +810 other locations
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

metastasis
paclitaxel
pemetrexed
squamous cell carcinoma
pembrolizumab
Southeastern Medical Oncology Center-Goldsboro
 (9.6 away) Contact site
  • 1103 views
  • 04 Aug, 2021
  • +1138 other locations
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

This randomized phase III trial studies lymph node dissection and radiation therapy to see how well it works compared to radiation therapy alone in treating patients with breast cancer previously treated with chemotherapy and surgery. Lymph node dissection may remove cancer cells that have spread to nearby lymph nodes in …

metastasis
estrogen receptor
lobular carcinoma
estrogen
ductal carcinoma in situ
Southeastern Medical Oncology Center-Goldsboro
 (9.6 away) Contact site
  • 476 views
  • 22 Jun, 2021
  • +741 other locations
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

This phase III trial studies combination chemotherapy and atezolizumab to see how well it works compared with combination chemotherapy alone in treating patients with stage III colon cancer and deficient deoxyribonucleic acid (DNA) mismatch repair. Drugs used in combination chemotherapy, such as oxaliplatin, leucovorin calcium, and fluorouracil, work in different …

fluorouracil
metastasis
monoclonal antibodies
investigational agent
platelet count
Southeastern Medical Oncology Center-Goldsboro
 (9.6 away) Contact site
  • 1047 views
  • 01 Aug, 2021
  • +589 other locations
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

This randomized research trial studies how well serum tumor marker directed disease monitoring works in monitoring patients with hormone receptor positive Her2 negative breast cancer that has spread to other places in the body. Using markers to prompt when scans should be ordered may be as good as the usual …

Southeastern Medical Oncology Center-Goldsboro
 (9.6 away) Contact site
  • 139 views
  • 19 May, 2021
  • +481 other locations
Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer

This phase III trial studies how well pembrolizumab works in treating patients with bladder cancer that has spread into the deep muscle of the bladder wall (muscle-invasive) or urothelial cancer that has spread from where it started to nearby tissue or lymph nodes (locally advanced). Monoclonal antibodies recognizing and blocking …

Southeastern Medical Oncology Center-Goldsboro
 (9.6 away) Contact site
  • 836 views
  • 04 Aug, 2021
  • +758 other locations